Gilead Sciences President John Milligan Interview

John Milligan, president and chief operating officer of Gilead Sciences Inc., speaks during an interview in New York, U.S., on Tuesday, Feb. 11, 2014. Gilead Sciences Inc., the world's largest maker of HIV medicines, received U.S. approval in December for Sovaldi, the treatment for hepatitis C it acquired in its $11 billion purchase of Pharmasset Inc. in 2012. Photographer: Victor J. Blue/Bloomberg via Getty Images
John Milligan, president and chief operating officer of Gilead Sciences Inc., speaks during an interview in New York, U.S., on Tuesday, Feb. 11, 2014. Gilead Sciences Inc., the world's largest maker of HIV medicines, received U.S. approval in December for Sovaldi, the treatment for hepatitis C it acquired in its $11 billion purchase of Pharmasset Inc. in 2012. Photographer: Victor J. Blue/Bloomberg via Getty Images
Gilead Sciences President John Milligan Interview
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesGilead Sciences President John Milligan Interview, News PhotoGilead Sciences President John Milligan Interview, News PhotoGilead Sciences President John Milligan Interview Get premium, high resolution news photos at Getty ImagesProduct #:468720965
$499$175
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
468720965
Collection:
Bloomberg
Date created:
February 11, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
GILEAD MILLIGAN